10-QPeriod: Q3 FY2025

Philip Morris International Inc. Quarterly Report for Q3 Ended Sep 30, 2025

Filed October 24, 2025For Securities:PM

Summary

Philip Morris International Inc. (PM) reported strong financial results for the nine months ended September 30, 2025, with a significant increase in net revenues and diluted earnings per share compared to the prior year. Net revenues grew by 7.5% to $30.3 billion, driven by favorable pricing across combustible tobacco and robust volume growth in smoke-free products, despite some unfavorable mix and lower cigarette volumes. Diluted earnings per share (EPS) saw a substantial increase of 20.4% to $5.89. This growth was supported by improved operating income, a lower effective tax rate, and reduced interest expenses. The company's strategic shift towards smoke-free products continues to gain momentum, with smoke-free revenues showing strong year-over-year growth. Key investments in manufacturing capacity for these products are underway, reflecting PMI's commitment to its long-term smoke-free future.

Financial Statements
Beta

Key Highlights

  • 1Net revenues increased by 7.5% to $30.3 billion for the nine months ended September 30, 2025, compared to the same period in 2024.
  • 2Diluted Earnings Per Share (EPS) grew by 20.4% to $5.89 for the nine months ended September 30, 2025.
  • 3Smoke-free product revenues showed strong growth, contributing significantly to the overall revenue increase.
  • 4Operating income rose by 13.6% to $11.5 billion for the nine months ended September 30, 2025, driven by higher revenues and favorable pricing.
  • 5The company experienced a lower effective tax rate of 19.2% for the nine months ended September 30, 2025, down from 23.1% in the prior year.
  • 6The Americas segment saw a decrease in net revenues due to pricing pressures and promotional activities, while other segments reported growth.
  • 7PMI prepaid approximately €3 billion of its senior unsecured term loan facility and maintained significant liquidity with $6.3 billion in committed revolving credit facilities, all of which were undrawn at the end of the period.

Frequently Asked Questions

The primary drivers for the 7.5% increase in net revenues were favorable pricing, particularly in combustible tobacco, and robust volume growth in smoke-free products. Despite some challenges with unfavorable mix and lower cigarette volumes, the overall performance was strong.

Smoke-free products performed very strongly, with revenues increasing significantly across all segments. This performance highlights the company's successful transition and commitment to its smoke-free future, with notable growth in markets like Europe, SSEA, CIS & MEA, and EA, AU & PMI GTR.

The company incurred several charges and recognized income that impacted comparability. These included restructuring charges in Germany ($243 million pre-tax), a Germany excise tax classification litigation charge ($176 million pre-tax), an impairment charge on a Wellness & Healthcare equity investment ($146 million after-tax), and income related to the RBH (Canada) Plan implementation, including dividend income ($156 million after-tax). These items are detailed in the notes to the financial statements.

PMI has a solid liquidity position, with $6.3 billion in committed revolving credit facilities, all of which were undrawn at the end of the period. The company also prepaid a significant portion of its term loan facility. Total debt was $50.1 billion as of September 30, 2025. The company expects to meet its liquidity requirements through a combination of operating cash flows, debt financing, and its commercial paper program.